Pacific Biosciences of California Company Profile (NASDAQ:PACB)

About Pacific Biosciences of California

Pacific Biosciences of California logoPacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company's Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. Based on its SMRT technology, the Company has introduced the PacBio RS II System. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Based on the Company's SMRT sequencing technology, its products enable de novo genome assembly to finish genomes in order to identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms and find genes; targeted sequencing to characterize genetic variations, and deoxyribonucleic acid (DNA) base modification identification to help characterize epigenetic regulation and DNA damage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: PACB
  • CUSIP: 69404D10
Key Metrics:
  • Previous Close: $9.02
  • 50 Day Moving Average: $8.63
  • 200 Day Moving Average: $8.70
  • 52-Week Range: $3.58 - $14.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.89
  • P/E Growth: -0.36
  • Market Cap: $828.71M
  • Outstanding Shares: 91,875,000
  • Beta: 2.89
Profitability:
  • Net Margins: -41.57%
  • Return on Equity: -77.61%
  • Return on Assets: -45.44%
Debt:
  • Debt-to-Equity Ratio: 0.14%
  • Current Ratio: 4.08%
  • Quick Ratio: 3.66%
Additional Links:
Companies Related to Pacific Biosciences of California:

Analyst Ratings

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $12.50 (38.58% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetDetails
6/29/2016Cantor FitzgeraldReiterated RatingBuy$18.00View Rating Details
6/27/2016CL KingInitiated CoverageBuy$11.00View Rating Details
4/15/2016MKM PartnersInitiated CoverageNeutral$16.50View Rating Details
4/14/2016First AnalysisInitiated CoverageOverweight$11.00View Rating Details
2/5/2016StephensReiterated RatingBuyView Rating Details
2/4/2016JPMorgan Chase & Co.Boost Price Target$10.00 -> $12.00View Rating Details
2/4/2016Piper Jaffray Cos.DowngradeOverweight -> Neutral$9.00 -> $11.00View Rating Details
10/23/2015William BlairReiterated RatingBuyView Rating Details
8/27/2015Maxim GroupReiterated RatingBuy$9.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Pacific Biosciences of California (NASDAQ:PACB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/20/2016        
8/4/2016Q2($0.22)($0.21)$20.19 million$20.70 millionViewN/AView Earnings Details
4/21/2016Q1($0.25)($0.23)$18.02 million$19.10 millionViewListenView Earnings Details
2/3/2016Q4($0.02)($0.02)$36.96 million$36.28 millionViewN/AView Earnings Details
10/22/2015Q3($0.27)$0.02$15.84 million$13.90 millionViewListenView Earnings Details
8/5/2015Q215($0.14)($0.16)$26.36 million$24.94 millionViewListenView Earnings Details
5/5/2015Q115($0.27)($0.27)$13.70 million$17.65 millionViewN/AView Earnings Details
2/3/2015Q414($0.26)($0.26)$14.90 million$16.90 millionViewListenView Earnings Details
10/23/2014Q214($0.16)($0.13)$17.20 million$20.60 millionViewListenView Earnings Details
7/24/2014Q114($0.15)($0.27)$11.39 million$11.40 millionViewN/AView Earnings Details
4/30/2014($0.28)($0.28)ViewN/AView Earnings Details
2/4/2014Q413($0.27)($0.26)$9.13 million$9.10 millionViewN/AView Earnings Details
10/22/2013Q313($0.30)($0.31)$7.08 million$7.40 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.35)($0.33)$6.09 million$6.04 millionViewN/AView Earnings Details
4/23/2013Q1 2013($0.37)($0.37)$4.28 million$5.60 millionViewN/AView Earnings Details
2/5/2013Q4 2012($0.37)($0.39)$4.38 million$5.90 millionViewN/AView Earnings Details
10/25/2012($0.45)($0.41)ViewN/AView Earnings Details
7/26/2012($0.46)($0.40)ViewN/AView Earnings Details
5/1/2012($0.47)($0.50)ViewN/AView Earnings Details
2/7/2012($0.50)($0.42)ViewN/AView Earnings Details
8/4/2011($0.63)($0.42)ViewN/AView Earnings Details
4/27/2011($0.67)($0.66)ViewN/AView Earnings Details
2/15/2011($0.91)($0.97)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pacific Biosciences of California (NASDAQ:PACB)
Current Year EPS Consensus Estimate: $-0.85 EPS
Next Year EPS Consensus Estimate: $-0.70 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.26)($0.26)
Q2 20162($0.23)($0.22)($0.23)
Q3 20162($0.21)($0.17)($0.19)
Q4 20162($0.21)($0.19)($0.20)
Q1 20171($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pacific Biosciences of California (NASDAQ:PACB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pacific Biosciences of California (NASDAQ:PACB)
Insider Ownership Percentage: 19.80%
Institutional Ownership Percentage: 66.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/29/2016James Michael PhillipsSVPSell20,000$8.45$169,000.00View SEC Filing  
4/25/2016James Michael PhillipsSVPSell20,000$10.29$205,800.00View SEC Filing  
3/2/2015Brian B DowVPBuy2,503$4.91$12,289.73View SEC Filing  
3/2/2015Kevin P CorcoranSVPBuy2,816$4.91$13,826.56View SEC Filing  
8/19/2014William W EricsonDirectorBuy39,299$5.14$201,996.86View SEC Filing  
8/18/2014William W EricsonDirectorBuy135,155$5.09$687,938.95View SEC Filing  
8/14/2014William W EricsonDirectorBuy77,822$5.00$389,110.00View SEC Filing  
8/13/2014William W EricsonDirectorBuy29,435$4.93$145,114.55View SEC Filing  
8/12/2014William W EricsonDirectorBuy123,423$4.89$603,538.47View SEC Filing  
12/12/2013Michael HunkapillerCEOBuy100,000$4.13$413,000.00View SEC Filing  
11/21/2013Michael HunkapillerCEOBuy200,000$3.61$722,000.00View SEC Filing  
12/3/2012Michael HunkapillerCEOBuy154,100$1.75$269,675.00View SEC Filing  
11/29/2012Michael HunkapillerCEOBuy242,200$1.68$406,896.00View SEC Filing  
11/26/2012Michael HunkapillerCEOBuy186,400$1.44$268,416.00View SEC Filing  
11/20/2012Michael HunkapillerCEOBuy155,000$1.27$196,850.00View SEC Filing  
11/16/2012Michael HunkapillerCEOBuy262,300$1.16$304,268.00View SEC Filing  
8/7/2012Michael HunkapillerCEOBuy400,000$1.75$700,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pacific Biosciences of California (NASDAQ:PACB)
DateHeadline
News IconHot Biotech Stocks Recap: Pacific Biosciences of California, Inc ... - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - September 27 at 11:15 AM
prnewswire.com logoDovetail Genomics Adds PacBio SMRT Sequencing and Assembly ... - PR Newswire (press release) (NASDAQ:PACB)
www.prnewswire.com - September 23 at 6:08 PM
News IconBiotech Stocks Worth Chasing: Pacific Biosciences of California, Inc ... - The Independent Republic (NASDAQ:PACB)
theindependentrepublic.com - September 23 at 6:08 PM
News IconHot Biotech Stocks Recap: Pacific Biosciences of California, Inc. (NASDAQ:PACB), ZIOPHARM Oncology, Inc ... - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - September 23 at 6:08 PM
finance.yahoo.com logoDovetail Genomics Adds PacBio SMRT Sequencing and Assembly to Its Services Menu (NASDAQ:PACB)
finance.yahoo.com - September 22 at 11:30 AM
investornewswire.com logoAnalysts Expect Pacific Biosciences of California, Inc. (NASDAQ:PACB) To Post EPS Of $-0.15 - Investor Newswire (NASDAQ:PACB)
www.investornewswire.com - September 20 at 11:55 AM
finance.yahoo.com logoPacific Biosciences draws upside bets (NASDAQ:PACB)
finance.yahoo.com - September 19 at 11:11 AM
investornewswire.com logoPacific Biosciences of California, Inc. (NASDAQ:PACB) Average ... - Investor Newswire (NASDAQ:PACB)
www.investornewswire.com - September 18 at 6:12 PM
realistinvestor.com logoPacific Biosciences of California, Inc. (NASDAQ:PACB) Mean Price Target Is $12.75 - RealistInvestor.com (NASDAQ:PACB)
www.realistinvestor.com - September 18 at 6:12 PM
News IconQuarterly Financial Review of Pacific Biosciences of California, Inc ... - Newburg Press (NASDAQ:PACB)
newburghpress.com - September 17 at 11:03 AM
News IconNews review of 2 biotech stocks: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Novavax, Inc. (NASDAQ:NVAX) - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - September 16 at 10:09 AM
News IconThe Key Numbers To Watch From Pacific Biosciences of California, Inc. (NASDAQ:PACB)'s Earnings - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - September 11 at 10:43 AM
istreetwire.com logoStocks in the Spotlight: Pacific Biosciences of California, Inc. (PACB), Media General, Inc. (MEG), Carrizo Oil ... - iStreetWire (NASDAQ:PACB)
istreetwire.com - September 8 at 10:29 AM
News IconIntraday Active Biotech Stocks News: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Vertex Pharmaceuticals ... - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - September 7 at 10:13 AM
realistinvestor.com logoPacific Biosciences of California, Inc. (NASDAQ:PACB)'s Growth Forecast - RealistInvestor.com (NASDAQ:PACB)
www.realistinvestor.com - September 3 at 5:53 PM
News IconHot Biotech Stocks Recap: Opko Health, Inc. (NASDAQ:OPK), Pacific Biosciences of California, Inc. (NASDAQ:PACB) - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - August 31 at 11:45 AM
News IconPacific Biosciences of California, Inc.'s (PACB): Stock in the Trader's Focus - Hot Stocks Point (NASDAQ:PACB)
www.hotstockspoint.com - August 23 at 6:52 PM
News IconShares Holding Above Moving Averages: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Post News (NASDAQ:PACB)
www.kentuckypostnews.com - August 19 at 6:39 PM
bloomberg.com logoIllumina Gains on Report of $30 Billion Thermo Fisher Offer (1) (NASDAQ:PACB)
washpost.bloomberg.com - August 19 at 9:43 AM
finance.yahoo.com logoPACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials (NASDAQ:PACB)
finance.yahoo.com - August 12 at 6:49 PM
capitalcube.com logoETF’s with exposure to Pacific Biosciences of California, Inc. : August 9, 2016 (NASDAQ:PACB)
www.capitalcube.com - August 9 at 6:58 PM
istreetwire.com logoTrader Alert: Macy's, Inc. (M), Kate Spade & Company (KATE), Pacific Biosciences of California, Inc. (PACB) - iStreetWire (NASDAQ:PACB)
istreetwire.com - August 8 at 6:56 PM
News IconTechnical Glance At Healthcare Stocks: Abbott Laboratories (NYSE ... - TWN (NASDAQ:PACB)
thewellesleysnews.com - August 8 at 6:56 PM
capitalcube.com logoPacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner : PACB-US : August 8, 2016 (NASDAQ:PACB)
www.capitalcube.com - August 8 at 11:23 AM
News IconEquity Research Analyst's Stock Ratings: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Cypress ... - TWN (NASDAQ:PACB)
thewellesleysnews.com - August 6 at 9:32 AM
finance.yahoo.com logoEdited Transcript of PACB earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:PACB)
finance.yahoo.com - August 6 at 9:32 AM
fool.com logoPacific Biosciences of California's Growth Engine Starting to Gain Momentum (NASDAQ:PACB)
www.fool.com - August 5 at 3:19 PM
fool.com logoWhy Shares of Pacific Biosciences of California Popped 19% Today (NASDAQ:PACB)
www.fool.com - August 5 at 1:54 PM
News IconPacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results (NASDAQ:PACB)
www.pharmiweb.com - August 5 at 9:47 AM
finance.yahoo.com logoPacific Biosciences (PACB) Q2 Impressive, View Encourages (NASDAQ:PACB)
finance.yahoo.com - August 5 at 9:47 AM
benzinga.com logoPacific Biosciences Releases New Software and Chemistry for Sequel System (NASDAQ:PACB)
www.benzinga.com - August 4 at 7:10 PM
rttnews.com logoEARNINGS SUMMARY: Details of Pacific Biosciences of California, Inc. Q2 Earnings Report (NASDAQ:PACB)
www.rttnews.com - August 4 at 7:10 PM
reuters.com logoBRIEF-Pacific Biosciences Of California Inc announces Q2 2016 financial results (NASDAQ:PACB)
www.reuters.com - August 4 at 7:10 PM
sg.finance.yahoo.com logoPacific Biosciences reports 2Q loss (NASDAQ:PACB)
sg.finance.yahoo.com - August 4 at 7:10 PM
biz.yahoo.com logoQ2 2016 Pacific Biosciences of California Inc Earnings Release - After Market Close (NASDAQ:PACB)
biz.yahoo.com - August 4 at 9:52 AM
News IconWhy Pacific Biosciences Shares Jumped 21.6% in July (NASDAQ:PACB)
host.madison.com - August 3 at 7:04 PM
News IconUpcoming Earnings Report: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - The Voice Registrar (NASDAQ:PACB)
voiceregistrar.com - August 3 at 9:57 AM
tradecalls.org logoBourne Lent Asset Management Inc buys $1428435 stake in Pacific Biosciences of California (PACB) - Trade Calls (NASDAQ:PACB)
www.tradecalls.org - August 2 at 11:39 AM
finance.yahoo.com logoPacific Biosciences (PACB) Q2 Earnings: What's in Store? (NASDAQ:PACB)
finance.yahoo.com - August 1 at 9:52 AM
publicnow.com logoHistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing (NASDAQ:PACB)
www.publicnow.com - August 1 at 8:41 AM
finance.yahoo.com logo7:32 am Pacific Biosciences receives a multi-year contract to perform HLA typing using PacBio sequencing (NASDAQ:PACB)
finance.yahoo.com - August 1 at 7:32 AM
realistinvestor.com logoCan Pacific Biosciences of California, Inc. (NASDAQ:PACB) Hit $18? - RealistInvestor.com (NASDAQ:PACB)
www.realistinvestor.com - July 31 at 6:11 PM
fortune.com logoLatest Pacific Biosciences of California, Inc. (NASDAQ:PACB) Target Price Suggests Stock Is Worth $12.5/Share - Review Fortune (NASDAQ:PACB)
reviewfortune.com - July 31 at 6:11 PM
capitalcube.com logoPacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner : PACB-US : July 29, 2016 (NASDAQ:PACB)
www.capitalcube.com - July 29 at 8:04 AM
streetupdates.com logoMost recent Analysts Rating report: Astrazeneca PLC (NYSE:AZN) , Pacific Biosciences of California, Inc. (NASDAQ ... - Street Updates (NASDAQ:PACB)
www.streetupdates.com - July 26 at 9:56 AM
realistinvestor.com logoWhat's The Growth Forecast For Pacific Biosciences of California ... - RealistInvestor.com (NASDAQ:PACB)
www.realistinvestor.com - July 24 at 10:51 AM
capitalcube.com logoETF’s with exposure to Pacific Biosciences of California, Inc. : July 18, 2016 (NASDAQ:PACB)
www.capitalcube.com - July 18 at 2:09 PM
realistinvestor.com logoPacific Biosciences of California, Inc. (NASDAQ:PACB)'s Growth Projection - RealistInvestor.com (NASDAQ:PACB)
www.realistinvestor.com - July 16 at 6:13 PM
news.cmlviz.com logoPacific Biosciences of California Inc Realized Volatility Hits Elevated Level - CML News (NASDAQ:PACB)
news.cmlviz.com - July 16 at 9:58 AM
News IconPacific Biosciences of California, Inc. (NASDAQ:PACB) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:PACB)
www.engelwooddaily.com - July 14 at 10:18 AM

Social

Pacific Biosciences of California (NASDAQ:PACB) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff